These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2664928)

  • 1. Doubling time of Mycobacterium lepraemurium in mouse footpads.
    Silbaq F; Levy L; Bercovier H
    Res Microbiol; 1989 Jan; 140(1):43-50. PubMed ID: 2664928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disease of CBA and BALB/c mice that follows inoculation of a small number of Mycobacterium lepraemurium into the hind foot pad.
    Silbaq F; Mor N; Levy L; Bercovier H
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):681-9. PubMed ID: 2280119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
    Roch F; Bach MA
    Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for generation of suppressor T cells in Mycobacterium lepraemurium-infected CBA/J mice, a mouse strain highly susceptible to the infection.
    Saito N; Hirooka Y
    Microbiol Immunol; 1983; 27(1):75-85. PubMed ID: 6223201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Mycobacterium lepraemurium infection in mice: differences in doubling time in liver, spleen, and bone marrow, and a method for measuring the proportion of viable organisms in an inoculum.
    Brown IN; Krenzien HN
    Infect Immun; 1976 Feb; 13(2):480-6. PubMed ID: 770330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity and delayed-type hypersensitivity in C57BL mice after immunization with live Mycobacterium lepraemurium and sonicated bacilli.
    Closs O; Løvik M
    Infect Immun; 1980 Jul; 29(1):17-23. PubMed ID: 6995335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a sustained protection against murine leprosy in C3H mice vaccinated with extracts of Mycobacterium lepraemurium in admixture with Mycobacterium bovis (BCG).
    Turcotte R; Lemieux S
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):494-500. PubMed ID: 6763006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of Mycobacterium lepraemurium in C57BL mice after acquired protective immunity.
    Løvik M; Closs O
    Clin Exp Immunol; 1984 Jul; 57(1):115-22. PubMed ID: 6378458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A histopathological study of pulmonary infection of mice with Mycobacterium lepraemurium.
    Ha DK; Lawton JW; Collins RJ
    J Comp Pathol; 1988 Nov; 99(4):421-9. PubMed ID: 3060483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death of Mycobacterium lepraemurium after multiplication in CBA, BALB/c and nude mice.
    Resnick M; Bercovier H; Aizer F; Mor N; Levy L
    Ann Inst Pasteur Microbiol; 1987; 138(1):15-9. PubMed ID: 2955800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low responsiveness to MLM bacilli associated with an impaired macrophage function in CBA/J mice.
    Saito N; Natori T
    Exp Clin Immunogenet; 1985; 2(1):24-35. PubMed ID: 2978828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacteria antibodies in M. lepraemurium murine infection.
    Bach MA; Hoffenbach A
    Acta Leprol; 1984; 2(2-4):403-11. PubMed ID: 6398599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells.
    Roch F; Bach MA
    Clin Immunol Immunopathol; 1991 Sep; 60(3):443-54. PubMed ID: 1907533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of delayed type hypersensitivity against ultrasonicated Mycobacterium lepraemurium bacilli without simultaneous local reactivity against live bacilli or protective immunity.
    Løvik M; Closs O
    Clin Exp Immunol; 1983 Aug; 53(2):319-27. PubMed ID: 6349877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of Mycobacterium lepraemurium in cell culture. II. Pathogenicity of Mycobacterium lepraemurium maintained in mouse foot pad cell culture and interaction of the bacilli with the infected cells.
    Matsuo Y
    Jpn J Microbiol; 1975 Aug; 19(4):319-25. PubMed ID: 1104936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental murine leprosy: induction of immunity and immune paralysis to Mycobacterium lepraemurium in C57BL mice.
    Closs O
    Infect Immun; 1975 Oct; 12(4):706-13. PubMed ID: 1104475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phorbol myristate acetate, a tumor-promoting agent, on the growth of Mycobacterium lepraemurium in the mouse footpad.
    Tomioka H; Saito H
    Microbiol Immunol; 1983; 27(5):395-407. PubMed ID: 6353178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responsiveness in Mycobacterium lepraemurium infections in a "resistant" (CBA) and a "susceptible" (BALB/c) mouse strain.
    Brett SJ
    Cell Immunol; 1984 Nov; 89(1):132-43. PubMed ID: 6386189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restored pathogenicity of attenuated Mycobacterium lepraemurium in mice.
    Nomaguchi H; Kohsaka K; Miyata Y; Mori T; Ito T
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):446-52. PubMed ID: 3528347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice.
    Lagrange PH; Hurtrel B
    Clin Exp Immunol; 1979 Dec; 38(3):461-74. PubMed ID: 394891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.